HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tetsu Hayashida Selected Research

Lobular Carcinoma

1/2020Impact of neoadjuvant and adjuvant chemotherapy on invasive lobular carcinoma: A propensity score-matched analysis of SEER data.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tetsu Hayashida Research Topics

Disease

29Neoplasms (Cancer)
03/2024 - 07/2005
29Breast Neoplasms (Breast Cancer)
02/2024 - 07/2006
6Colorectal Neoplasms (Colorectal Cancer)
01/2019 - 07/2010
5Neoplasm Metastasis (Metastasis)
08/2020 - 01/2010
3Triple Negative Breast Neoplasms
02/2024 - 02/2011
2Stomach Neoplasms (Stomach Cancer)
03/2021 - 03/2019
2Acute Liver Failure (Fulminant Hepatic Failure)
04/2015 - 12/2010
1Noninfiltrating Intraductal Carcinoma (DCIS)
01/2023
1Glycogen Storage Disease Type I
01/2023
1Lung Neoplasms (Lung Cancer)
10/2020
1Adenocarcinoma of Lung
10/2020
1Lobular Carcinoma
01/2020
1Chronic Disease (Chronic Diseases)
01/2020
1Lymphatic Metastasis
01/2020
1Fatigue
01/2020
1Carcinoma (Carcinomatosis)
01/2019
1Disease Progression
01/2019
1Hypoxia (Hypoxemia)
01/2019
1Vomiting
01/2019
1Nausea
01/2019
1Esophageal Squamous Cell Carcinoma
10/2017
1Esophageal Neoplasms (Esophageal Cancer)
10/2017
1Rectal Prolapse
01/2017
1Ascites
01/2017
1Meigs Syndrome (Meig's Syndrome)
01/2017
1Inflammation (Inflammations)
04/2015

Drug/Important Bio-Agent (IBA)

7Estrogen ReceptorsIBA
02/2023 - 07/2006
5Proteins (Proteins, Gene)FDA Link
03/2024 - 07/2005
5Biomarkers (Surrogate Marker)IBA
07/2023 - 02/2011
5ErbB Receptors (EGF Receptor)IBA
10/2020 - 01/2013
5Epidermal Growth Factor (EGF)IBA
07/2018 - 02/2011
4Hormones (Hormone)IBA
01/2019 - 06/2012
3Progesterone Receptors (Progesterone Receptor)IBA
02/2023 - 08/2015
3Phenobarbital (Luminal)FDA Link
04/2021 - 01/2012
3Messenger RNA (mRNA)IBA
10/2020 - 07/2010
3LigandsIBA
08/2020 - 02/2011
3human ERBB2 proteinIBA
07/2019 - 06/2014
3AnthracyclinesIBA
07/2019 - 06/2018
3Capecitabine (Xeloda)FDA Link
07/2018 - 01/2012
2Fatty Acids (Saturated Fatty Acids)IBA
02/2024 - 01/2019
2ParaffinIBA
01/2023 - 01/2019
2eribulinFDA Link
07/2021 - 06/2018
2taxaneIBA
07/2019 - 06/2018
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2019 - 05/2014
2TamoxifenFDA LinkGeneric
01/2019 - 06/2014
2Hematoxylin (Haematoxylon)IBA
01/2019 - 12/2012
2Eosine Yellowish-(YS) (Eosin)IBA
01/2019 - 12/2012
2Epirubicin (Ellence)FDA LinkGeneric
07/2018 - 01/2012
2HMGB1 Protein (HMG1)IBA
04/2015 - 12/2010
2Cetuximab (Erbitux)FDA Link
05/2014 - 01/2013
2Transcription Factors (Transcription Factor)IBA
02/2012 - 01/2010
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
02/2012 - 01/2010
1abemaciclibIBA
02/2024
1palbociclibIBA
02/2024
1Cyclin-Dependent Kinase 4IBA
02/2024
1Proton Pump InhibitorsIBA
02/2024
1Androgen Receptors (Androgen Receptor)IBA
02/2023
1hypotaurineIBA
01/2023
1polysulfideIBA
01/2023
1Formaldehyde (Formol)FDA Link
01/2023
1Glucose-6-Phosphatase (Glucose 6 Phosphatase)IBA
01/2023
1Glucose-6-PhosphateIBA
01/2023
1beta-Aminoethyl Isothiourea (AET)IBA
03/2022
1Circulating Tumor DNAIBA
09/2021
13- (4- methylphenylsulfonyl)- 2- propenenitrileIBA
07/2021
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
03/2021
1Tyrosine Kinase InhibitorsIBA
10/2020
1Indicators and Reagents (Reagents)IBA
10/2020
1Selective Estrogen Receptor Modulators (SERM)IBA
08/2020
1Aromatase InhibitorsIBA
08/2020
1RNA (Ribonucleic Acid)IBA
01/2020
1PlatinumIBA
12/2019
1Etoposide (VP 16)FDA LinkGeneric
12/2019
1PolyaminesIBA
10/2019
1Trastuzumab (Herceptin)FDA Link
07/2019
1Vascular Endothelial Growth Factor DIBA
03/2019
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
03/2019
1Vascular Endothelial Growth Factor CIBA
03/2019
1Keratins (Keratin)IBA
01/2019
1AntiemeticsIBA
01/2019
1Olanzapine (Zyprexa)FDA Link
01/2019
1Oxygen (Dioxygen)IBA
01/2019
1Aprepitant (Emend)FDA Link
01/2019
1Green Fluorescent ProteinsIBA
01/2019
1E2F Transcription FactorsIBA
07/2018
1GemcitabineFDA Link
07/2018
1Cytotoxins (Cytolysins)IBA
07/2018
1Thymidylate SynthaseIBA
07/2018
1Lapatinib (GW572016)FDA Link
07/2018
1Dihydrotachysterol (AT 10)IBA
06/2018
1Electron Transport Complex IV (Cytochrome c Oxidase)IBA
10/2017
1CaspasesIBA
10/2017

Therapy/Procedure

9Therapeutics
03/2022 - 06/2010
8Drug Therapy (Chemotherapy)
01/2020 - 04/2011
4Neoadjuvant Therapy
07/2019 - 12/2012
3Adjuvant Chemotherapy
01/2020 - 04/2011
1Genomic Medicine
02/2021
1Ovariectomy (Oophorectomy)
01/2017
1Lymph Node Excision (Lymph Node Dissection)
01/2016
1Cautery
01/2016